Rice Hall James & Associates’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-32,971
Closed -$8.49M 320
2021
Q2
$8.49M Sell
32,971
-4,768
-13% -$1.23M 0.3% 73
2021
Q1
$11.3M Sell
37,739
-153
-0.4% -$45.9K 0.37% 64
2020
Q4
$9.66M Sell
37,892
-1,637
-4% -$417K 0.34% 63
2020
Q3
$9.84M Buy
39,529
+1,807
+5% +$450K 0.4% 62
2020
Q2
$13.1M Sell
37,722
-1,180
-3% -$410K 0.56% 53
2020
Q1
$10.4M Sell
38,902
-893
-2% -$239K 0.58% 50
2019
Q4
$12.9M Sell
39,795
-1,383
-3% -$448K 0.44% 91
2019
Q3
$11.3M Sell
41,178
-822
-2% -$225K 0.4% 96
2019
Q2
$22.4M Sell
42,000
-2,691
-6% -$1.44M 0.74% 39
2019
Q1
$22.5M Buy
44,691
+1,424
+3% +$718K 0.73% 40
2018
Q4
$21.3M Buy
43,267
+12,998
+43% +$6.41M 0.78% 38
2018
Q3
$27.7M Sell
30,269
-723
-2% -$661K 0.99% 26
2018
Q2
$22.7M Buy
30,992
+259
+0.8% +$190K 0.83% 32
2018
Q1
$49M Sell
30,733
-37,889
-55% -$60.4M 1.91% 7
2017
Q4
$61.5M Sell
68,622
-13,865
-17% -$12.4M 2.42% 1
2017
Q3
$29.7M Sell
82,487
-3,494
-4% -$1.26M 1.31% 10
2017
Q2
$25.2M Buy
85,981
+17,638
+26% +$5.17M 1.1% 18
2017
Q1
$24.1M Sell
68,343
-245
-0.4% -$86.3K 1.17% 10
2016
Q4
$12.6M Sell
68,588
-1,262
-2% -$232K 0.64% 71
2016
Q3
$18M Buy
69,850
+7,654
+12% +$1.97M 0.94% 44
2016
Q2
$13.3M Buy
62,196
+855
+1% +$183K 0.76% 63
2016
Q1
$12.7M Buy
61,341
+1,372
+2% +$283K 0.73% 58
2015
Q4
$15.2M Buy
59,969
+25,171
+72% +$6.36M 0.87% 50
2015
Q3
$5.72M Buy
34,798
+2,787
+9% +$458K 0.37% 74
2015
Q2
$6.01M Sell
32,011
-3,161
-9% -$593K 0.35% 78
2015
Q1
$5.8M Buy
35,172
+4,499
+15% +$742K 0.34% 84
2014
Q4
$7.13M Buy
30,673
+4,990
+19% +$1.16M 0.43% 61
2014
Q3
$4.65M Buy
25,683
+13,594
+112% +$2.46M 0.32% 71
2014
Q2
$2.33M Buy
12,089
+3,823
+46% +$735K 0.16% 175
2014
Q1
$1.5M Buy
8,266
+3,680
+80% +$669K 0.11% 209
2013
Q4
$781K Buy
4,586
+2,883
+169% +$491K 0.06% 234
2013
Q3
$267K Sell
1,703
-359
-17% -$56.3K 0.03% 262
2013
Q2
$357K Buy
+2,062
New +$357K 0.04% 242